Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
May 28, 2024 - Page 5 of 5 - The Dermatology Digest
Subscribe
Search

Day: May 28, 2024

J & J to Acquire Rights to a Clinical-Stage Bispecific Antibody Targeting AD

Johnson & Johnson is set to acquire rights to NM26, a bi-specific antibody for the treatment of atopic dermatitis (AD), through an agreement with Numab Therapeutics to acquire its wholly owned subsidiary Yellow Jersey Therapeutics (YJT). NM26, which is ready to enter Phase 2 studies, targets interleukin (IL) -4R alpha subunit (IL-4Rα) and IL-31 to […]